In other studies, genetically engineered mice used to study causative mutations in small cell lung carcinoma (SCLC) were transfected with adeno-associated viral vectors containing gRNAs specifically designed to target the SCLC predisposing mutations in tumor suppressors TP53 and RB1 [19]. The gene discussed is TP53; the disease is neoplasm.